EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Update
by Renee Jackson · The Cerbat GemEssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 3,624 shares, a decline of 82.0% from the April 30th total of 20,151 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 195,258 shares, the days-to-cover ratio is presently 0.0 days.
Analyst Ratings Changes
Separately, Deutsche Bank Aktiengesellschaft initiated coverage on EssilorLuxottica in a research note on Tuesday, May 12th. They issued a “hold” rating on the stock. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, EssilorLuxottica has a consensus rating of “Buy”.
Read Our Latest Research Report on EssilorLuxottica
EssilorLuxottica Stock Up 0.5%
EssilorLuxottica stock traded up $0.50 during midday trading on Friday, reaching $102.04. The stock had a trading volume of 45,061 shares, compared to its average volume of 116,630. EssilorLuxottica has a 12 month low of $96.56 and a 12 month high of $186.81. The company has a fifty day moving average price of $109.49 and a two-hundred day moving average price of $140.10. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99.
EssilorLuxottica Company Profile
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.